• 검색 결과가 없습니다.

COVID-19 Testing Method

N/A
N/A
Protected

Academic year: 2022

Share "COVID-19 Testing Method"

Copied!
1
0
0

로드 중.... (전체 텍스트 보기)

전체 글

(1)

COVID-19 Testing Method (RT-PCR)

Performer

Venue Procedure

Specimen

Collection

medical staff

separate space

※ chance of infection

Required device

Collect a sample

from the PUI*’s nostrils/sputum

using a swab, and put the swab

into a tube containing

Universal Transport Medium (* PUI : Person Under Investigation)

Universal Transport Medium*

(or viral transport medium)

(* preserves and cultivates the virus)

RNA

extraction

expert Class ∥ bio-safety

cabinet that can control air

flow

(personal protective equipment

needed)

※ chance of infection

Option Merit/demerit

Extract the RNA from the sample

gained in stage

 by using a reagent for extracting nucleic acid and create a

separate sample containing only

the RNA.

when done by humans

(+) only requires personal protective equipment (-) skilled staff needed

* can perform about 100 tests per day

when done by automated

devices

(+) consistent performance (-) takes 2-4 weeks to set up,

high cost

Amplifica

-tion/Test

expert

lab

Required device

Amplify the RNA in the

sample from stage  using reagents, test kits, and a PCR device. Then,

run an assay to see whether the results come out

positive or negative.

test kit*

* nine products in South Korea approved for exportation

qPCR device

&

computer

Diagnosis

medical specialist/

Diagnosticians lab

※ When diagnosing COVID-19, be aware of the possibility of “false negative“, in which patients who are actually positive can be tested negative due to a low concentration of the virus.

Make the final diagnosis.

참조

관련 문서

This paper presents find- ings from a global survey on the extent of worldwide exposure to the COVID-19 infodemic, assesses different populations’ susceptibility to false claims, and

Currently, indications for administering remdesivir in COVID-19 are mainly patients with severe lower respiratory disease.. Although the formal standard for severe COVID-19 has not

This study analyzed symptoms and clinical characteristics of confirmed COVID-19 patients admitted to COVID-19 hospitals in Uzbekistan.. Therefore, this study is of considerable

CQ, HCQ Early (potential) Anti-malaria • No benefits for hospitalized COVID-19 patients Anti-rheumatoid arthritis (HCQ) • Ongoing phase 1 trials as prophylaxis for COVID-19

Chest radiographic and CT findings of the 2019 novel coronavirus disease (COVID-19):.. analysis of nine patients treated

A study on anxiety, knowledge, infection possibility, preventive possibility and preventive behavior level of COVID-19 in general public.. A comparative study of the current

The event study method applied to Oil and Gas industry index data around three event days includes: (i) The date Vietnam recognized the first patient to be COVID-19

In this study, we investigated virus contamination by col- lecting environmental swab samples and air samples from negative pressure isolation rooms of patients with